Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 11, 2006 - Issue 1
Submit an article Journal homepage
97
Views
5
CrossRef citations to date
0
Altmetric
Review

Emerging drugs for chronic lymphocytic leukaemia

Karen WL Yee Fellow, University of Texas MD Anderson Cancer Center, Department of Leukaemia, 1515 Holcombe Boulevard, Box 428, Houston, Texas 77030, USA
&
Susan M O’Brien Professor, University of Texas MD Anderson Cancer Center, Department of Leukaemia, 1515 Holcombe Boulevard, Houston, Texas 77030, USA. [email protected]
Pages 167-189 | Published online: 27 Feb 2006

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Manzoor A Mir & Javed N Agrewala. (2008) Signaling through CD80: an approach for treating lymphomas. Expert Opinion on Therapeutic Targets 12:8, pages 969-979.
Read now

Articles from other publishers (4)

Manzoor Ahmad Mir. 2015. Developing Costimulatory Molecules for Immunotherapy of Diseases. Developing Costimulatory Molecules for Immunotherapy of Diseases 185 254 .
C. Pepper, J. G. Mahdi, A. G. S. Buggins, S. Hewamana, E. Walsby, E. Mahdi, A. Al-Haza’a, A. J. Mahdi, T. T. Lin, L. Pearce, L. Morgan, I. D. Bowen, P. Brennan & C. Fegan. (2011) Two novel aspirin analogues show selective cytotoxicity in primary chronic lymphocytic leukaemia cells that is associated with dual inhibition of Rel A and COX-2. Cell Proliferation 44:4, pages 380-390.
Crossref
Sivasubramanian Baskar, Jessica M. Suschak, Ivan Samija, Ramaprasad Srinivasan, Richard W. Childs, Steven Z. Pavletic, Michael R. Bishop & Christoph Rader. (2009) A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display. Blood 114:20, pages 4494-4502.
Crossref
Ningyan Zhang, Brent R. Williams, Ping Lu, Zhiqiang An & Chen-Ni Chin. 2009. Therapeutic Monoclonal Antibodies. Therapeutic Monoclonal Antibodies 711 762 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.